[1]
2018. Immune Biomarkers of Percutaneous Coronary Intervention Adverse Outcomes in Myocardial Infarction and Stable Angina Patients.
Asian Journal of Pharmaceutics (AJP)
. 12, 03 (Nov. 2018). DOI:
https://doi.org/10.22377/ajp.v12i03.2653
.